MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2024 International Congress

    A UK-wide Effort for Identification of Loci for Autosomal Dominant Parkinson’s Disease

    R. Tilney, R. Real, S. Jasaityte, Z. Fang, M. Fenn, L. Lange, A. Singleton, C. Blauwendraat, C. Klein, H. Morris, GP2. Genetic Program (London, United Kingdom)

    Objective: (i) To describe the demographic, clinical and genetic features of a large cohort of familial autosomal dominant Parkinson’s disease (PD) patients in the UK.(ii)…
  • 2024 International Congress

    The Inhibition of Mitochondrial NLRP3 Inflammasome Decreases Dopaminergic Cell Death in a 6-OHDA Mouse Model of Parkinson’s Disease.

    E. Dalle, O. Ondoua Nguele, H. Bayaga (Yaounde, Cameroon)

    Objective: To evaluate the possible neuroprotective effects of mitochondrial NLRP3 inflammasome inhibition in a 6-hydroxydopamine mouse model of Parkinson's Disease. Background: Overactivation of brain immune…
  • 2024 International Congress

    Wilson’s Disease About A Complex Case

    A. Ouedraogo, V. Ouedraogo, A. Savadogo (Bobo-Dioulasso, Burkina Faso)

    Objective: We report the case of a patient who experienced diagnostic wavering. Background: Wilson disease is a rare disease. Cases in Africa is even rarer.…
  • 2024 International Congress

    Plasma MicroRNA Expression Profiling in patients with Multiple System Atrophy and Parkinson’s Disease

    R. Yadav, P. Ramaswamy, PK. Pal, R. Christopher (Bengaluru, India)

    Objective: Our objective was to identify differentially expressed, circulating miRNAs in Multiple System Atrophy-Parkinsonian type (MSA-P) and Parkinson’s disease (PD) which could serve as diagnostic…
  • 2024 International Congress

    Mild Behavioral Impairment in Lewy body disease: a potential marker of phenoconversion and disease severity

    B. Jin, E. Yoon, S. Kim, S. Lee, H. Nam, Y. Kim, B. Jeon, J. Lee (Seoul, Republic of Korea)

    Objective: To explore the association between mild behavioral impairment (MBI) and disease severity in a predefined prospective cohort with Lewy body disease (LBD) spectrum Background:…
  • 2024 International Congress

    Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?

    A. Martinez Nunez, N. Walker-Pizarro, A. Wagle Shukla, A. Ramirez-Zamora, N. Mcfarland (Gainesvile, USA)

    Objective: To examine the utility of commercially available skin phosphorylated alpha-synuclein deposition test (pSyn) in patients with clinically ambiguous parkinsonism and its concordance with dopamine…
  • 2024 International Congress

    Parkinsonism in setting of hypoparathyroidism

    R. Fekete (Hawthorne, USA)

    Objective: There may be overlap between symptoms of hypoparathyroidism such as tremor and bradykinesia and Parkinsonism. Recognizing this possibility allows for appropriate clinical management. Background:…
  • 2024 International Congress

    Association between Parkinsonism, Parkinson’s Disease and Cognitive Impairment and Incidence of Dementia in People with Parkinsonism and Parkinson’s Disease in Latin America: A 10/66 Dementia Research Group Study

    N. Khan, M. Arruabarrena, D. Kim, M. Jiang, J. Llibre-Rodriguez, A. Salgado, I. Acosta, A. Sosa, D. Acosta, I. Jimenez-Velasquez, M. Guerra, A. Salas, L. Contreras, H. Hesse, C. Tanner, M. Prina, J. Guerra (Newcasle Upon Tyne, United Kingdom)

    Objective: The study aimed to determine the cross-sectional and prospective associations between parkinsonism and Parkinson's disease with cognitive impairment and dementia in a large multi-country…
  • 2024 International Congress

    Spectrum of Movement Disorders in Kazakhstan: Five Years of Insights from Kazakhstan’s First Movement Disorder Center

    ZH. Myrzayev, CH. Shashkin, G. Seidakhmetova, B. Abdenov, R. Kaiyrzhanov (Almaty, Kazakhstan)

    Objective: To describe the spectrum, demographics, and trends of movement disorders patients seen at the first movement disorder (MD) center in Kazakhstan over five years.To…
  • 2024 International Congress

    Pre-treatment with Methanolic Extract Mucuna pruriens Seeds Attenuates Serotonin Gene Depletion, Motor Dysfunction and Anxiogenic Responses in a Rat Model of Parkinsonism

    A. Obajuluwa, B. Laoye, J. Okwuaka, T. Obajuluwa, J. Lech, A. Oremosu (Ado -Ekiti, Nigeria)

    Objective: Investigate neuroprotective and genoprotective effects of methanolic Mucuna pruriens (Mp) seed extract in a paraquat-induced Parkinsonism rat model. Background: Paraquat exposure has been linked…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 388
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley